LONDON, March 20, 2017 /PRNewswire/ --
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 304-page report you will receive 124 tables and 97 figures - all unavailable elsewhere.
The 304-page report provides clear detailed insight into the global antibacterial drugs market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope • Global Antibacterial Drugs Market forecasts from 2017-2027
• Revenue forecasts for the 6 leading submarkets from 2017-2027: - Cephalosporins - Penicillins - Fluoroquinolones - Macrolides - Carbapenems - Others
• Revenue forecasts for the 43 leading marketed antibacterial drugs from 2017-2027: - Cephalosporins: Rocephin, Sulperazon, Ceftin/Zinnat, Meiact, Flomox, Teflaro, Zeftera, Ceftolozane-tazobactam, Ceftazidime-Avibactam - Penicillins: Generic amoxicillin, Augmentin, Zosyn/Tazocin, Unasyn, Generic amoxicllin-clavulanic acid, Amoxil - Fluoroquinolones: Avelox, Cravit, Vigamox, Ciprodex, Cipro/Ciprobay, Geninax, Defafloxacin - Macrolides: Biaxin/Clarith, Zithromax, Dalacin, Dificid, Solithromycin - Carbapenems: Invanz, Merrem/Meropen, Primaxin, Doribax - Other antibacterial drugs: Zyvox, Cubicin, Tygacil, TOBI/TIP, Solodyn, Vibativ, Sirturo, Tedizolid, Oritavancin, Dalbavancin, Nemonoxacin, Surotomycin
To see a report overview please email Sara Peerun on [email protected]
• Revenue forecasts for the leading developed and emerging national and regional markets. Markets forecasted in this report are the following: - The US - The EU: France, Germany, Italy, Spain, the UK, and others - Japan - The BRIC countries: Brazil, Russia, India, China - South Korea - The Rest of the World
• Analysis of the strengths, weaknesses as well as the opportunities and threats of the antibacterial drugs industry and market
• Coverage of antibacterial drug candidates in the R&D pipeline. Discussions of research and development - see progress in this industry, finding technological, clinical and commercial outlooks and opportunities
Visiongain's study is intended for anyone requiring commercial analyses for the Global Antibacterial Drugs Market. You find data, trends and predictions.
Buy our report today Global Antibacterial Drugs Market 2017-2027: Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems and Others.
To request a report overview of this report please email Sara Peerun at [email protected] or call Tel: +44-(0)-20-7336-6100
Or click on: https://www.visiongain.com/Report/1821/Global-Antibacterial-Drugs-Market-2017-2027
Companies Mentioned
Abbott Laboratories
AbbVie
Achaogen
Actavis
Actelion
Affinium Pharmaceutical
AiCuris GmbH & Co. KG
Alcon
Alkem Laboratories
Allergan
Allied Pharma
Apotex
APP Pharmaceuticals
Aptalis Pharma
Aquapharm Biodiscovery
Aradigm
Aridis Pharmaceuticals
Ascend Therapeutics
Astellas Pharma
AstraZeneca
Aurobindo Pharma
Barr Pharmaceuticals
Basilea Pharmaceuticals
Bayer Laboratories
Biomax Biotechnics
Bristol-Myers Squibb
Cadila Healthcare
Calixa Therapeutics
Cardeas Pharma
Cellceutix
Cempra Pharmaceuticals
Cipla
Claris Lifesciences
Cornerstone Biopharma
Cornerstone Therapeutics
Corona Remedies
Critical Therapeutics
Cubist Pharmaceuticals
Daiichi Sankyo
Dainippon Sumitomo
Discuva
Dr. Reddy's Laboratories
Durata Therapeutics
Eli Lilly
Emcure Pharmaceuticals
Eros Pharma
Forest Laboratories
Furiex Pharmaceuticals
Gate Pharma
Gilead Sciences
Glenmark
GlycoVaxyn
GlaxoSmithKline (GSK)
Hetero
Hi-Tech Pharma
Hikma Farmaceutica
Hospira
Insmed
Intercell
Itochu Chemical Frontier
Janssen Pharmaceuticals
Johnson & Johnson
KaloBios
Kenta Biotech
Kuhnil Pharm
Lupin
Macleod Pharmaceuticals
Medicis
MedImmune
Meiji
Melinta Therapeutics
Merck & Co.
Merlion Pharmaceuticals
Microlabs
MicuRx Pharmaceuticals
Mpex Pharmaceuticals
Mylan
Nabriva Therapeutics
Nalneva
Neiss Labs
Nektar Therapeutics
Novacta Biosystems
Novartis
Novexel
Optimer Biotechnology
Orchid Chemicals
Orchid Healthcare
Ortho-McNeil
Paratek Pharmaceuticals
Peninsula Pharmaceuticals
Pfizer
Pharmacia
Phico Therapeutics
Piramal Healthcare
Plenus Pharmaceuticals
Pliva
Polyphor
Procarta Biosystems
Procter & Gamble Pharmaceuticals
Ranbaxy
Redx Pharma
Roche
Roxane
R-Pharma
Sagent Pharmaceuticals
Sandoz
Sanofi
Savara Pharmaceuticals
Sawai Pharmaceutical
Schering Plough
Seika Pharma
Sequella
Shanghai MengKe Pharmaceuticals
Shionogi
Shire
Sidmak Labs
Solitaire Pharmacia
Specialised Therapeutics Australia
Sunovion Pharma
TaiGen Biotechnology
Taisho Toyama
Takeda
TAP Holdings
Targanta Therapeutics
Tetraphase Pharmaceuticals
Teva Pharmaceutical Industries
The Medicines Company
Theravance
Torrent Pharmaceuticals
Trius Therapeutics
TTY Biopharma
Unichem Laboratories
Valeant Pharmaceuticals
Vansen Pharma
ViroPharma
Warner Chilcott
Watson
Wockhardt
Zhejiang Medicine Company
Zuellig Pharma
Zydus Pharmaceuticals
To see a report overview please email Sara Peerun on [email protected]
SOURCE Visiongain Ltd
Advertisement
Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems and Others
The global antibacterial drugs market is expected to grow at a CAGR of 1.3% in the first half of the forecast period and a CAGR of 3.1% in the second half of the forecast period. The market is estimated at $41.76bn in 2016 and $44.54bn in 2021.
Advertisement
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 304-page report you will receive 124 tables and 97 figures - all unavailable elsewhere.
The 304-page report provides clear detailed insight into the global antibacterial drugs market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope • Global Antibacterial Drugs Market forecasts from 2017-2027
• Revenue forecasts for the 6 leading submarkets from 2017-2027: - Cephalosporins - Penicillins - Fluoroquinolones - Macrolides - Carbapenems - Others
• Revenue forecasts for the 43 leading marketed antibacterial drugs from 2017-2027: - Cephalosporins: Rocephin, Sulperazon, Ceftin/Zinnat, Meiact, Flomox, Teflaro, Zeftera, Ceftolozane-tazobactam, Ceftazidime-Avibactam - Penicillins: Generic amoxicillin, Augmentin, Zosyn/Tazocin, Unasyn, Generic amoxicllin-clavulanic acid, Amoxil - Fluoroquinolones: Avelox, Cravit, Vigamox, Ciprodex, Cipro/Ciprobay, Geninax, Defafloxacin - Macrolides: Biaxin/Clarith, Zithromax, Dalacin, Dificid, Solithromycin - Carbapenems: Invanz, Merrem/Meropen, Primaxin, Doribax - Other antibacterial drugs: Zyvox, Cubicin, Tygacil, TOBI/TIP, Solodyn, Vibativ, Sirturo, Tedizolid, Oritavancin, Dalbavancin, Nemonoxacin, Surotomycin
To see a report overview please email Sara Peerun on [email protected]
• Revenue forecasts for the leading developed and emerging national and regional markets. Markets forecasted in this report are the following: - The US - The EU: France, Germany, Italy, Spain, the UK, and others - Japan - The BRIC countries: Brazil, Russia, India, China - South Korea - The Rest of the World
• Analysis of the strengths, weaknesses as well as the opportunities and threats of the antibacterial drugs industry and market
• Coverage of antibacterial drug candidates in the R&D pipeline. Discussions of research and development - see progress in this industry, finding technological, clinical and commercial outlooks and opportunities
Visiongain's study is intended for anyone requiring commercial analyses for the Global Antibacterial Drugs Market. You find data, trends and predictions.
Buy our report today Global Antibacterial Drugs Market 2017-2027: Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems and Others.
To request a report overview of this report please email Sara Peerun at [email protected] or call Tel: +44-(0)-20-7336-6100
Or click on: https://www.visiongain.com/Report/1821/Global-Antibacterial-Drugs-Market-2017-2027
Companies Mentioned
Abbott Laboratories
AbbVie
Achaogen
Actavis
Actelion
Affinium Pharmaceutical
AiCuris GmbH & Co. KG
Alcon
Alkem Laboratories
Allergan
Allied Pharma
Apotex
APP Pharmaceuticals
Aptalis Pharma
Aquapharm Biodiscovery
Aradigm
Aridis Pharmaceuticals
Ascend Therapeutics
Astellas Pharma
AstraZeneca
Aurobindo Pharma
Barr Pharmaceuticals
Basilea Pharmaceuticals
Bayer Laboratories
Biomax Biotechnics
Bristol-Myers Squibb
Cadila Healthcare
Calixa Therapeutics
Cardeas Pharma
Cellceutix
Cempra Pharmaceuticals
Cipla
Claris Lifesciences
Cornerstone Biopharma
Cornerstone Therapeutics
Corona Remedies
Critical Therapeutics
Cubist Pharmaceuticals
Daiichi Sankyo
Dainippon Sumitomo
Discuva
Dr. Reddy's Laboratories
Durata Therapeutics
Eli Lilly
Emcure Pharmaceuticals
Eros Pharma
Forest Laboratories
Furiex Pharmaceuticals
Gate Pharma
Gilead Sciences
Glenmark
GlycoVaxyn
GlaxoSmithKline (GSK)
Hetero
Hi-Tech Pharma
Hikma Farmaceutica
Hospira
Insmed
Intercell
Itochu Chemical Frontier
Janssen Pharmaceuticals
Johnson & Johnson
KaloBios
Kenta Biotech
Kuhnil Pharm
Lupin
Macleod Pharmaceuticals
Medicis
MedImmune
Meiji
Melinta Therapeutics
Merck & Co.
Merlion Pharmaceuticals
Microlabs
MicuRx Pharmaceuticals
Mpex Pharmaceuticals
Mylan
Nabriva Therapeutics
Nalneva
Neiss Labs
Nektar Therapeutics
Novacta Biosystems
Novartis
Novexel
Optimer Biotechnology
Orchid Chemicals
Orchid Healthcare
Ortho-McNeil
Paratek Pharmaceuticals
Peninsula Pharmaceuticals
Pfizer
Pharmacia
Phico Therapeutics
Piramal Healthcare
Plenus Pharmaceuticals
Pliva
Polyphor
Procarta Biosystems
Procter & Gamble Pharmaceuticals
Ranbaxy
Redx Pharma
Roche
Roxane
R-Pharma
Sagent Pharmaceuticals
Sandoz
Sanofi
Savara Pharmaceuticals
Sawai Pharmaceutical
Schering Plough
Seika Pharma
Sequella
Shanghai MengKe Pharmaceuticals
Shionogi
Shire
Sidmak Labs
Solitaire Pharmacia
Specialised Therapeutics Australia
Sunovion Pharma
TaiGen Biotechnology
Taisho Toyama
Takeda
TAP Holdings
Targanta Therapeutics
Tetraphase Pharmaceuticals
Teva Pharmaceutical Industries
The Medicines Company
Theravance
Torrent Pharmaceuticals
Trius Therapeutics
TTY Biopharma
Unichem Laboratories
Valeant Pharmaceuticals
Vansen Pharma
ViroPharma
Warner Chilcott
Watson
Wockhardt
Zhejiang Medicine Company
Zuellig Pharma
Zydus Pharmaceuticals
To see a report overview please email Sara Peerun on [email protected]
SOURCE Visiongain Ltd
